- Activation of Peroxisome Proliferator-Activated Receptor-γ Decreases Pancreatic Cancer Cell Invasion through Modulation of the Plasminogen Activator System
Hirozumi Sawai et al, 2006, Molecular Cancer Research CrossRef - A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes
Chunhua Qin et al, 2004, Molecular Cancer Therapeutics CrossRef - Peroxisome Proliferator-Activated Receptor γ Is Highly Expressed in Pancreatic Cancer and Is Associated With Shorter Overall Survival Times
Glen Kristiansen et al, 2006, Clinical Cancer Research CrossRef - Chronic Pancreatitis and Pancreatic Cancer
Xiangyu Kong et al, 2014, Gastrointestinal Tumors CrossRef - Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways
Fahad Khan et al, 2024, Frontiers in Cell and Developmental Biology CrossRef - Role of PPAR γ and EGFR signalling in the urothelial terminal differentiation programme
Claire L. Varley et al, 2004, Journal of Cell Science CrossRef - Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth
Laura A. Marlow et al, 2009, Cancer Research CrossRef - How cancer cells remodel lipid metabolism: strategies targeting transcription factors
Do-Won Jeong et al, 2021, Lipids in Health and Disease CrossRef - Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancer
Ammu V. V. V. Ravi Kiran et al, 2022, Investigational New Drugs CrossRef